John J V McMurray

John J V McMurray

UNVERIFIED PROFILE

Are you John J V McMurray?   Register this Author

Register author
John J V McMurray

John J V McMurray

Publications by authors named "John J V McMurray"

Are you John J V McMurray?   Register this Author

100Publications

1954Reads

46Profile Views

Income level and inequality as complement to geographical differences in cardiovascular trials.

Am Heart J 2019 Dec 1;218:66-74. Epub 2019 Sep 1.

Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2019.08.019DOI Listing
December 2019

MRAs in Elderly HF Patients: Individual Patient-Data Meta-Analysis of RALES, EMPAHSIS-HF, and TOPCAT.

JACC Heart Fail 2019 Dec;7(12):1012-1021

Université de Lorraine, Centre d'Investigation Clinique-Plurithématique INSERM 1433, and Cardiovascular and Renal Clinical Trialists, INSERM U1116, CHRU Nancy Brabois, Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.08.017DOI Listing
December 2019

Mean BMI, visit-to-visit BMI variability and BMI changes during follow-up in patients with acute myocardial infarction with systolic dysfunction and/or heart failure: insights from the High-Risk Myocardial Infarction Initiative.

Clin Res Cardiol 2019 Nov 5;108(11):1215-1225. Epub 2019 Apr 5.

Université de Lorraine, INSERM, Centre d'Investigation Clinique et Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-019-01453-7DOI Listing
November 2019

PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction.

Cardiovasc Res 2019 Nov;115(13):e136-e139

Institute of Cardiovascular & Medical Sciences, University of Glasgow, Scotland, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cvr/cvz223DOI Listing
November 2019

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

N Engl J Med 2019 11 19;381(21):1995-2008. Epub 2019 Sep 19.

From the BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (J.J.V.M., M.C.P., K.F.D., P.S.J.); the Cardiovascular Division (S.D.S., A.S.D.) and the TIMI Study Group, Brigham and Women's Hospital and Harvard Medical School (M.S.S.) - all in Boston; Section of Endocrinology, Yale University School of Medicine, New Haven, CT (S.E.I.); Rigshospitalet Copenhagen University Hospital (L.K.) and the Department of Cardiology, Gentofte University Hospital (M. Schou), Copenhagen; the Department of Medicine, Saarland University Hospital, Homburg-Saar, Germany (M.B.); Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.); National University of Cordoba, Cordoba (F.A.M.), and the Division of Cardiology, Instituto Cardiovascular de Buenos Aires, Buenos Aires (M.D.) - both in Argentina; Wroclaw Medical University, Wroclaw (P.P.), and the Department of Cardiology, Medical University of Lodz, Lodz (J.D.) - both in Poland; the Department of Cardiology, University of Minnesota, Minneapolis (I.S.A.); 2nd Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital and 1st Faculty of Medicine, Charles University, Prague, Czech Republic (J.B.); the Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan (C.-E.C.); the Department of Cardiology, Medanta, Gurgaon, India (V.K.C.); the Department of Cardiology, University Medical Center and University of Groningen, Groningen, the Netherlands (R.A.B.); the 5th Department of Internal Medicine, Comenius University in Bratislava, Bratislava, Slovakia (A.D.); the Department of Cardiology, Shanghai Institute of Cardiovascular Disease and Zhongshan Hospital Fudan University, Shanghai, China (J.G.); Cumming School of Medicine and Libin Cardiovascular Institute, University of Calgary, Calgary, AB (J.G.H.), the Department of Cardiology, Montreal Heart Institute, Montreal (E.O.), and the Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Toronto (S.V.) - all in Canada; Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.); the Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.); the Department of Molecular and Clinical Medicine and Cardiology, Sahlgrenska Academy (C.E.A.L.), and AstraZeneca (O.B., M. Sjöstrand, A.M.L.), Gothenburg, and the Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University (C.H.), Uppsala - all in Sweden; the Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.); Instituto do Coracao, Hospital das Clinicas da Faculdade de Medicina, Universidade de São Paolo, São Paolo (J.C.N.); the Department of Internal Medicine, Tan Tao University, Tan Duc, Vietnam (P.N.V.); the Department of Myocardial Disease and Heart Failure, National Medical Research Center of Cardiology, Moscow (S.T.); and the Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison (D.L.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1911303DOI Listing
November 2019

Lung ultrasound: monitoring congestion in patients with heart failure.

Eur J Heart Fail 2019 Nov 8. Epub 2019 Nov 8.

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1636DOI Listing
November 2019

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

N Engl J Med 2019 10 1;381(17):1609-1620. Epub 2019 Sep 1.

From the Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston (S.D.S., M.A.P., A.S.D., B.C.); the British Heart Foundation Cardiovascular Research Centre (J.J.V.M., P.S.J.) and the Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Well-being (J.C.), University of Glasgow, Glasgow, and the National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London (J.C.) - all in the United Kingdom; University of Minnesota, Minneapolis (I.S.A), and Mayo Clinic, Rochester (M.M.R.) - both in Minnesota; Shanghai Institute of Cardiovascular Diseases (J. Ge) and the Department of Cardiology (J.Z.), Zhongshan Hospital, Fudan University, Shanghai, China; National Heart Center Singapore and Duke-National University of Singapore, Singapore (C.S.P.L); National Association of Hospital Cardiologists Research Center, Florence (A.P.M.), and the Cardiology Division, Cardiovascular Department, Hospital Papa Giovanni XXIII, Bergamo (M.S.) - both in Italy; National University of Cordoba, Cordoba, Argentina (F.M.); Baylor University Medical Center, Dallas (M.P.); the Department of Internal Medicine and Cardiology, German Center for Cardiovascular Research partner site Berlin (B.P.), and the Department of Cardiology, Charité Universitätsmedizin, Campus Virchow-Klinikum (H.-D.D.) - both in Berlin; Institut de Cardiologie de Montréal, Université de Montréal, Montreal (J.L.R.); the Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (D.J.V.); INSERM Centre d'Investigation Clinic 1433 and Université de Lorraine, Centre Hospitalier Régional et Universitaire, Nancy, France (F.Z.); Medical University of South Carolina and the Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston (M.R.Z.); National Research Center for Cardiology of the Ministry of Health of the Russian Federation, Moscow (S.A.B.); Community Heart Failure Program, Department of Cardiology, Bellvitge University Hospital and Bellvitge Institute for Biomedical Research, University of Barcelona, Barcelona (J.C.-C.); Department of Heart Failure-Transplantation, National Cardiovascular Institute, Bratislava, Slovakia (E.G.); Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.); Disciplina de Cardiologia Faculdade de Medicina Pontifícia Universidade Católica de Campinas, São Paulo (J.F.K.S.); the Department of Noninvasive Cardiology, Medical University of Lodz, Lodz, Poland (M.L.); Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.); Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago (S.J.S); and Novartis Pharmaceuticals, East Hanover, NJ (A.R.R., J. Gong, V.C.S., M.P.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1908655DOI Listing
October 2019

Lung Ultrasound in Acute Heart Failure: Prevalence of Pulmonary Congestion and Short- and Long-Term Outcomes.

JACC Heart Fail 2019 Oct;7(10):849-858

British Heart Foundation (BHF) Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.07.008DOI Listing
October 2019

Visit-to-visit blood pressure variation and outcomes in heart failure with reduced ejection fraction: findings from the Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms trial.

J Hypertens 2019 Oct 3. Epub 2019 Oct 3.

Université de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000002275DOI Listing
October 2019

Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.

Heart 2019 Sep 8;105(17):1325-1334. Epub 2019 Apr 8.

BHF Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/heartjnl-2018-314381DOI Listing
September 2019

World Heart Federation Roadmap for Heart Failure.

Glob Heart 2019 09;14(3):197-214

Hatter Institute for Cardiovascular Research in Africa, Department of Cardiology and Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gheart.2019.07.004DOI Listing
September 2019

Optimizing heart failure treatment following cardiac resynchronization therapy.

Clin Res Cardiol 2019 Sep 26. Epub 2019 Sep 26.

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-019-01553-4DOI Listing
September 2019

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction.

Clin Res Cardiol 2019 Aug 28;108(8):868-877. Epub 2019 Jan 28.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-019-01415-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652172PMC
August 2019

Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure.

Eur J Heart Fail 2019 Aug 6;21(8):1022-1031. Epub 2019 Jun 6.

Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1504DOI Listing
August 2019

From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5).

J Am Coll Cardiol 2019 Aug;74(5):683-698

The Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.04.068DOI Listing
August 2019

Phosphodiesterase-9 Inhibition in Heart Failure: A Further Opportunity to Augment the Effects of Natriuretic Peptides?

J Am Coll Cardiol 2019 Aug;74(7):902-904

Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom. Electronic address: https://twitter.com/Kieranfdocherty.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.07.008DOI Listing
August 2019

Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate.

Clin Res Cardiol 2019 Jul 2;108(7):806-814. Epub 2019 Jan 2.

Department of Epidemiology and Preventive Medicine, CCRE Therapeutics, Monash University/Alfred Hospital, 553 St Kilda Rd, Melbourne, VIC, 3004, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-018-1410-4DOI Listing
July 2019

Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.

Curr Atheroscler Rep 2019 Jul 27;21(10):41. Epub 2019 Jul 27.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11883-019-0800-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660504PMC
July 2019

Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it.

Eur J Heart Fail 2019 Jun 11;21(6):699-702. Epub 2019 Apr 11.

BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618029PMC
June 2019

Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.

JACC Heart Fail 2019 Jun 8;7(6):457-465. Epub 2019 May 8.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.02.015DOI Listing
June 2019

Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction.

Korean Circ J 2019 Jun;49(6):469-484

British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4070/kcj.2019.0136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554586PMC
June 2019

The Serendipitous Story of SGLT2 Inhibitors in Heart Failure.

Circulation 2019 May 18;139(22):2537-2541. Epub 2019 Mar 18.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (J.J.V.M.).

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.0
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040514DOI Listing
May 2019

Urinalysis: A Window to the Heart.

JACC Heart Fail 2019 May;7(5):402-403

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2019.04.002DOI Listing
May 2019

Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction.

Int J Cardiol 2019 Apr 2;281:179-185. Epub 2018 Jun 2.

Institute of Cardiovascular & Medical Sciences, University of Glasgow, Scotland, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2018.05.124DOI Listing
April 2019

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis.

JACC Heart Fail 2019 Apr 6;7(4):336-346. Epub 2019 Feb 6.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2018.11.005DOI Listing
April 2019

Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial.

Eur J Heart Fail 2019 03 15;21(3):345-351. Epub 2019 Feb 15.

National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, University of Lorraine, Regional University Hospital of Nancy, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), Nancy, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ejhf.1400
Publisher Site
http://dx.doi.org/10.1002/ejhf.1400DOI Listing
March 2019

T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF.

Clin Res Cardiol 2019 Feb 26;108(2):133-141. Epub 2018 Jul 26.

Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Nydalen, P. B. 4950, 0424, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00392-018-1331-2DOI Listing
February 2019

Diabetic cardiomyopathy.

Heart 2019 Feb 18;105(4):337-345. Epub 2018 Oct 18.

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2016-310342
Publisher Site
http://dx.doi.org/10.1136/heartjnl-2016-310342DOI Listing
February 2019

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.

N Engl J Med 2019 01 26;380(5):447-458. Epub 2018 Oct 26.

From the Department of Renal Medicine, King's College Hospital (I.C.M., C.W.), and University College London (D.C.W.), London, Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School, Hull (S.B.), Lister Hospital, Stevenage (K.F.), and University of Hertfordshire, Hertfordshire (K.F.), the Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford (P.A.K.), the British Heart Foundation Cardiovascular Research Centre (J.J.V.M.) and the Robertson Centre for Biostatistics (H.M., I.F.), University of Glasgow, Glasgow, Freeman Hospital, Newcastle upon Tyne (C.R.V.T.), and the Oxford Kidney Unit, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford (C.G.W.) - all in the United Kingdom; and the Division of Cardiology and Metabolism, Department of Cardiology, Berlin-Brandenburg Center for Regenerative Therapies, German Center for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin Berlin, Berlin (S.D.A.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1810742
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1810742DOI Listing
January 2019

Response by Claggett et al to Letter Regarding Article, "Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials".

Circulation 2019 01;139(3):422-423

Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (B.C., M.A.P., S.D.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038478DOI Listing
January 2019

Talking to patients with heart failure about end of life.

Eur J Heart Fail 2018 12 8;20(12):1763-1765. Epub 2018 Oct 8.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ejhf.1321
Publisher Site
http://dx.doi.org/10.1002/ejhf.1321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607510PMC
December 2018

Redefining heart failure phenotypes based on ejection fraction.

Eur J Heart Fail 2018 12 17;20(12):1634-1635. Epub 2018 Oct 17.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1325DOI Listing
December 2018

Who Benefits From a Defibrillator-Balancing the Risk of Sudden Versus Non-sudden Death.

Curr Heart Fail Rep 2018 12;15(6):376-389

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11897-018-0416-6
Publisher Site
http://dx.doi.org/10.1007/s11897-018-0416-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267371PMC
December 2018

Risk stratification according to insulin type: reply.

Eur J Heart Fail 2018 10 31;20(10):1498. Epub 2018 May 31.

Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ejhf.1218DOI Listing
October 2018

Association is not causation: treatment effects cannot be estimated from observational data in heart failure.

Eur Heart J 2018 10;39(37):3417-3438

British Heart Foundation Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, 126 University Place, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehy407DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166137PMC
October 2018

SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.

Diabetologia 2018 10 22;61(10):2108-2117. Epub 2018 Aug 22.

British Heart Foundation, Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00125-018-4670-7
Publisher Site
http://dx.doi.org/10.1007/s00125-018-4670-7DOI Listing
October 2018

Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA.

Eur Heart J 2018 Oct 23. Epub 2018 Oct 23.

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehy609DOI Listing
October 2018

Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials.

Circulation 2018 08;138(6):570-577

Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (B.C., M.A.P., S.D.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.033065DOI Listing
August 2018

Catheter Ablation for Atrial Fibrillation with Heart Failure.

N Engl J Med 2018 08;379(5):491-2

University of Glasgow, Glasgow, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1806519DOI Listing
August 2018

Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns.

Circ Heart Fail 2018 07;11(7):e004926

Université de Lorraine INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, France (J.P.F., K.D., P.R., F.Z.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.118.004926DOI Listing
July 2018

Risk of Incident Heart Failure in Patients With Diabetes and Asymptomatic Left Ventricular Systolic Dysfunction.

Diabetes Care 2018 06 6;41(6):1285-1291. Epub 2018 Apr 6.

BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, U.K.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc17-2583DOI Listing
June 2018

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.

JACC Heart Fail 2018 06 11;6(6):489-498. Epub 2018 Apr 11.

British Heart Foundation (BHF) Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2018.02.004DOI Listing
June 2018

Prognostic Modeling in Heart Failure: Time for a Reboot.

JACC Heart Fail 2018 06;6(6):463-464

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchf.2018.03.020DOI Listing
June 2018

Only Trials Tell the Truth About Treatment Effects.

J Am Coll Cardiol 2018 06;71(23):2640-2642

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2018.04.019DOI Listing
June 2018

Incidence, Predictors, and Outcomes Associated With Hypotensive Episodes Among Heart Failure Patients Receiving Sacubitril/Valsartan or Enalapril: The PARADIGM-HF Trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure).

Circ Heart Fail 2018 04;11(4):e004745

Minneapolis VA Health Care System and University of Minnesota (O.V.). University of Colorado, Aurora (S.M.P.). Brigham and Women's Hospital, Harvard University, Boston, MA (B.C., A.S.D., S.D.S.). Novartis Pharmaceuticals Corporation, East Hanover, NJ (J.K., M.L., V.S.). University of Glasgow, United Kingdom (J.J.V.M.). Baylor University Medical Center, Dallas, TX (M.P.). Université de Montréal, Canada (J.R.). Medical University of South Carolina, Charleston (M.R.Z.). University of Gothenburg, Sweden (K.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004745DOI Listing
April 2018